Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study

BACKGROUND: The breast cancer treatment paradigm has shifted to neoadjuvant treatment. There are many advantages to neoadjuvant treatment, such as tumor downsizing, in vivo tumor biology testing, treating micrometastasis, and achieving complete pathological response (a surrogate marker for overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chirappapha, Prakasit, Chatmongkonwat, Tanet, Lertsithichai, Panuwat, Pipatsakulroj, Wiriya, Sritara, Chanika, Sukarayothin, Thongchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548931/
https://www.ncbi.nlm.nih.gov/pubmed/33072308
http://dx.doi.org/10.1016/j.amsu.2020.09.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548931/
https://www.ncbi.nlm.nih.gov/pubmed/33072308
http://dx.doi.org/10.1016/j.amsu.2020.09.030

Ejemplares similares